Results 111 to 120 of about 18,346 (199)

Targeting Menin in T-lineage Acute Lymphoblastic Leukemia. [PDF]

Mol Cancer Ther
Shimamoto K, Karaoglu DA, Arnold O, Dhar A, Chan Z, Giordano G, Cheng JX, Youshanlouei HR, Patel AA, DuVall AS, Drazer MW, Kessler L, Burrows F, Odenike O, Thirman MJ, Stock W, Saygin C.   +16 more
europepmc   +1 more source

Two Decades of <i>NPM1</i>-Mutated Acute Myeloid Leukemia: From Molecular Insights to Clinical Decision-Making. [PDF]

Cancers (Basel)
Cimino G, Caridi M, Celenza R, Millucci F, Crocioni M, Sciabolacci S, Cardinali V, Martelli MP.   +7 more
europepmc   +1 more source

Targeting DOT1L Epigenetic Moonlighting in MLL-Rearranged Leukemia. [PDF]

Cells
Gupta DG, Gupta M, Othman AH, Memon UA, Schiltz GE, Abdulkadir SA.   +5 more
europepmc   +1 more source

Menin-dependent megakaryocyte proliferation and fibrosis in myeloproliferative neoplasms. [PDF]

Cancer Cell
Wen J, Cotton A, Mehmood R, Mohan M, Hall T, Broadhurst AL, Zhang K, Olufadi Y, Kang G, Marcellino B, Mascarenhas J, Hoffman R, Janke LJ, Gurbuxani S, McGeehan GM, Crispino JD.   +15 more
europepmc   +1 more source

Menin inhibition reshapes therapy in <i>NPM1</i>-mutated acute myeloid leukemia. [PDF]

Ann Transl Med
Htut TW, Yilmaz M.
europepmc   +1 more source

Menin Inhibition in Acute Myeloid Leukemia: Rewiring Leukemic Transcriptional Networks. [PDF]

Int J Mol Sci
Tarhini A, Romanos M, Al-Kali A, Saliba AN.   +3 more
europepmc   +1 more source

Menin inhibitors as a treatment for acute leukemia: from bench to the clinic. [PDF]

Blood Neoplasia
Watts J, Madarang E, Cierpicki T, Grembecka J.   +3 more
europepmc   +1 more source

Combining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia. [PDF]

Blood Adv
Scheidegger N, Schneider C, Alexe G, Wang YC, Alonzo TA, Basanthakumar A, Bourgeois WA, Dudkiewicz-Garbicz J, Khalid D, Merickel LA, Perry JA, Ries RE, Salhotra S, Taillon A, Gamis A, Aplenc R, Harris MH, Wunderlich M, Armstrong SA, Pollard JA, Meshinchi S, Pikman Y, Stegmaier K.   +22 more
europepmc   +1 more source

Successful treatment of relapsed <i>KMT2A</i> rearranged AML with central nervous system involvement using revumenib in combination with venetoclax and azacitidine: A case report. [PDF]

Ther Adv Hematol
Xu J, Chen Y, Zhang Y, Zhang F, Zhang Y, Sun J, Xu N.   +6 more
europepmc   +1 more source

Introduzione. La filosofia del «promeneur solitaire»

, 2017
Marco Menin, Lorenzo Rustighi
core